A Case of Complete Remission Achieved Through Stereotactic Radiotherapy for Isolated Bone Metastasis Following Four Courses of Bleomycin, Etoposide, and Cisplatin Chemotherapy for Testicular Cancer
Kentaro Arinami, Gen Kawaguchi, Kozue Ito, Yurie Takizawa, Go Hasegawa, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama
{"title":"A Case of Complete Remission Achieved Through Stereotactic Radiotherapy for Isolated Bone Metastasis Following Four Courses of Bleomycin, Etoposide, and Cisplatin Chemotherapy for Testicular Cancer","authors":"Kentaro Arinami, Gen Kawaguchi, Kozue Ito, Yurie Takizawa, Go Hasegawa, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama","doi":"10.1002/iju5.70080","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>We report a case of nonseminoma germ cell tumor, in which solitary bone metastasis was detected by magnetic resonance imaging (MRI) after systemic chemotherapy, and resolution was achieved with stereotactic radiotherapy.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>A 42-year-old man was diagnosed with right-sided testicular cancer, T1N1M0, and right high orchiectomy was performed. Pathology revealed a mixed germ cell tumor. He received four 3-week courses of chemotherapy (BEP). Although computed tomography showed no new metastases, whole-body MRI revealed a solitary bone metastasis to the left sacrum, and stereotactic radiotherapy of 36.8 Gy/8f was administered to the same area. After radiotherapy, the accumulation in that area disappeared on MRI.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>As evidence accumulates, it is likely that whole-body MRI will become a useful observational method for staging and monitoring patients with germ cell tumors. Stereotactic radiotherapy may be used as consolidation therapy for patients with residual masses after systemic therapy.</p>\n </section>\n </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 5","pages":"508-512"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70080","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJU Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iju5.70080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
We report a case of nonseminoma germ cell tumor, in which solitary bone metastasis was detected by magnetic resonance imaging (MRI) after systemic chemotherapy, and resolution was achieved with stereotactic radiotherapy.
Case Presentation
A 42-year-old man was diagnosed with right-sided testicular cancer, T1N1M0, and right high orchiectomy was performed. Pathology revealed a mixed germ cell tumor. He received four 3-week courses of chemotherapy (BEP). Although computed tomography showed no new metastases, whole-body MRI revealed a solitary bone metastasis to the left sacrum, and stereotactic radiotherapy of 36.8 Gy/8f was administered to the same area. After radiotherapy, the accumulation in that area disappeared on MRI.
Conclusion
As evidence accumulates, it is likely that whole-body MRI will become a useful observational method for staging and monitoring patients with germ cell tumors. Stereotactic radiotherapy may be used as consolidation therapy for patients with residual masses after systemic therapy.